Hiroshi Sato

956 total citations
15 papers, 828 citations indexed

About

Hiroshi Sato is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hiroshi Sato has authored 15 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Hiroshi Sato's work include Viral-associated cancers and disorders (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Hiroshi Sato is often cited by papers focused on Viral-associated cancers and disorders (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Hiroshi Sato collaborates with scholars based in Japan, United States and South Korea. Hiroshi Sato's co-authors include Motoharu Seiki, Mitsuru Furukawa, Tomokazu Yoshizaki, Shigeyuki Murono, Toshiyuki Horikawa, Bruce P. Himelstein, Edward J. Lee, Noboru Fujimoto, Yasunori Okada and Takeshi Kinoshita and has published in prestigious journals such as Cancer, Oncogene and Journal of neurosurgery.

In The Last Decade

Hiroshi Sato

15 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroshi Sato Japan	13	497	420	284	141	128	15	828
Taketoshi Shimada Japan	15	443 0.9×	381 0.9×	313 1.1×	139 1.0×	82 0.6×	40	918
G N van Muijen Netherlands	13	263 0.5×	267 0.6×	472 1.7×	75 0.5×	165 1.3×	13	928
M. Eber France	14	420 0.8×	356 0.8×	265 0.9×	108 0.8×	160 1.3×	24	793
Paula Fukushima United States	13	474 1.0×	389 0.9×	319 1.1×	268 1.9×	110 0.9×	17	1.1k
Sirpa Salo Finland	19	420 0.8×	341 0.8×	464 1.6×	77 0.5×	602 4.7×	33	1.3k
David W. Cottam United Kingdom	9	278 0.6×	266 0.6×	219 0.8×	61 0.4×	107 0.8×	14	669
Arthur Kwok Leung Cheung Hong Kong	18	337 0.7×	362 0.9×	698 2.5×	42 0.3×	62 0.5×	27	1.1k
Martin Illemann Denmark	19	608 1.2×	478 1.1×	373 1.3×	75 0.5×	137 1.1×	39	1.2k
Peet Nooijen Netherlands	13	279 0.6×	146 0.3×	341 1.2×	43 0.3×	154 1.2×	30	844
Tibor Görögh Germany	21	412 0.8×	235 0.6×	444 1.6×	32 0.2×	49 0.4×	64	1.2k

Countries citing papers authored by Hiroshi Sato

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Sato more than expected).

Fields of papers citing papers by Hiroshi Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Sato. The network helps show where Hiroshi Sato may publish in the future.

Co-authorship network of co-authors of Hiroshi Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Sato. A scholar is included among the top collaborators of Hiroshi Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Sato. Hiroshi Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sato, Hiroshi, et al.. (2024). A case of cutaneous small vessel vasculitis after the seventh dose of COVID‐19 vaccination. Journal of General and Family Medicine. 26(2). 163–165. 1 indexed citations

Nakada, Mitsutoshi, Daisuke Kita, Kazuya Futami, et al.. (2001). Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Journal of neurosurgery. 94(3). 464–473. 76 indexed citations

Horikawa, Toshiyuki, Naohiro Wakisaka, Haruo Takeshita, et al.. (2001). Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.. PubMed. 7(7). 1946–51. 93 indexed citations

Kim, Kwang-Rok, Tomokazu Yoshizaki, Hisashi Miyamori, et al.. (2000). Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene. 19(14). 1764–1771. 90 indexed citations

Yamanaka, Hajime, Kenichi Makino, Masayuki Takizawa, et al.. (2000). Expression and Tissue Localization of Membrane-Types 1, 2, and 3 Matrix Metalloproteinases in Rheumatoid Synovium. Laboratory Investigation. 80(5). 677–687. 65 indexed citations

Yoshizaki, Tomokazu, et al.. (2000). Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma.. PubMed. 126(2). 69–73. 33 indexed citations

Yoshizaki, Tomokazu, Hiroshi Sato, Shigeyuki Murono, Joseph S. Pagano, & Mitsuru Furukawa. (1999). Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator. Clinical & Experimental Metastasis. 17(5). 431–436. 36 indexed citations

Himelstein, Bruce P., et al.. (1997). Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene. 14(16). 1995–1998. 97 indexed citations

Yoshizaki, Tomokazu, Hiroshi Sato, Yumiko Maruyama, et al.. (1997). Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 79(1). 139–144. 102 indexed citations

10.

Kinoshita, Takeshi, Hiroshi Sato, Takahisa Takino, et al.. (1996). Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.. PubMed. 56(11). 2535–8. 98 indexed citations

11.

Lengyel, Ernst, Rebecca J. Gum, J. Juárez, et al.. (1995). Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.. PubMed. 55(4). 963–7. 68 indexed citations

12.

Endo, Yoshio, Motoharu Seiki, Hiroyuki Uchida, et al.. (1992). Experimental Metastasis of Oncogene‐transformed NIH 3T3 Cells in Chick Embryo. Japanese Journal of Cancer Research. 83(3). 274–280. 13 indexed citations

13.

Seiki, Motoharu, Hiroshi Sato, Lance A. Liotta, & Elliott Schiffmann. (1991). Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: Human melanoma and ras‐transfected NIH3T3 cells. International Journal of Cancer. 49(5). 717–720. 17 indexed citations

14.

Tanaka, Junji, et al.. (1991). Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology. 185(1). 271–280. 38 indexed citations

15.

Sato, Hiroshi, et al.. (1987). Establishment of an Epstein-Barr Virus (EBV) Genome-Positive Subline of Ramos (Ramos/NPC) Following Infection of Ramos with Nasopharyngeal Carcinoma (NPC)-Derived EBV. Auris Nasus Larynx. 14(2). 87–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact